Infectious Disease Pharmacology | Conference Preview @GIBLIB
Infectious Disease Pharmacology | Conference Preview  @GIBLIB
Uploaded August 2022 | Updated November 2026, 2 hours ago
Bryce M. Kayhart, PharMD, RPh discusses the foundations of antimicrobial therapy and impact of pharmacodynamics on developing treatment plans.


Watch the full video at watch.giblib.com/video/8689?conference_id=140&order=10
Check out other videos in this conference at watch.giblib.com/conferences/140/physician-assistant-board-review/videos


Interested in CME? Conveniently earn unlimited AMA PRA Category 1 Credit(s)™ by subscribing to GIBLIB’s premium plan.


GIBLIB is increasing access to credible medical updates and the highest quality medical education by partnering with the best in medicine, such as Mayo Clinic, University of California San Francisco, Cleveland Clinic, Cedars-Sinai Medical Center, Hospital for Special Surgery, Stanford Children’s Hospital and more.


Learn more about GIBLIB at giblib.com
Visit our blog at giblib.com/blog


⟡ Follow Us ⟡
Instagram: instagram.com/giblib
Facebook: facebook.com/thegiblibapp
Twitter: twitter.com/theGIBLIBapp
LinkedIn: linkedin.com/company/giblib


#pharmacy #mayoclinic #PA
Infectious Disease Pharmacology | Conference PreviewCardiac and Vascular Pharmacology | Conference PreviewBreaking the Glass Ceiling: Lessons Learned from Leading a DepartmentOstomy, Fistula, ITD, IAD, Pressure Injury Wound CareEmotional Intelligence for Impactful LeadershipEndoscopic Weight Loss Through the Mouth Techniques | Conference PreviewDifficult Conversations: Opioids (ACGME Core Competency)Mayo Clinic Opioid Course Introduction with Halena M. Gazelka, MDHow to ensure adequate cauterization of the liver during laparoscopic cholecystectomy #shortsPresentation of heat exhaustion and differences from heat stroke #shortsMusculoskeletal Review | Conference PreviewRegenerative Medicine: Between Hype and Hope – What’s Really Possible? | Conference Preview
GIBLIB |

Infectious Disease Pharmacology | Conference Preview

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER